Tuesday, April 17, 2012 9:34:32 AM
Thanks for trying to post the write up on Yahoo. Sometimes they will take the content and sometimes they won't. I guess we are dealing with a Yahoo computer program because there never is an explanation.
jdb_1234,
You are welcome. Here is one more indication that the DS Waters operations may be in pretty good shape. Kelso, considered putting DSW up for sale in October of 2010. This was prior to DSW's last four acquisitions so DSW should be performing with higher operating numbers now than back then. Nevertheless, here is what Businessweek had to say about the possible sale:
DS Waters Reportedly Up For Sale
Oct 29 10
DS Waters of America Inc. will be divested in an auction expected to fetch up to $700 million, people close to the situation said. The people stated that a private equity company is most likely to acquire DS Waters. They added that the auction was still in its initial stages and the company may not be sold if the offers are too low. Buyout groups may be interested in the company, as it has steady sales and regular cash flow, the people said.
I'll try to answer your specific questions. It is tough to try to guess what kind of capital gains may be realized from the preferred equity as we don't know all the terms associated with the preferred. We think we know they are five year issues with a 15% rate, with no conversion features. So their value may be governed by interest rates coupled with the fortunes of DS Waters. So even though the capital gains on the preferred may be limited, the 15% coupon makes for a great return. And yes, PIK income is reported quarterly on the income statement even though it is not received quarterly but instead added to the principal amount. And PIK income is included when satisfying the annual distribution requirements of a RIC (Regulated Investment Company). That is why we don't want to see too much PIK income coming from the portfolio companies. But keep in mind that the restructuring did not add any new PIK income to the SLRC income flow since both the old notes and the new preferred both were PIK income loans and in the same amounts.
We should get an update on the DSW situation when SLRC reports Q1 on May 1st which is just eleven trading days from now. There should be no material fallout from this refinancing. I say that because in a recent update to a SLRC N-2 filing SLRC said:
"Recent Portfolio Developments
Subsequent to December 31, 2011, DSW Group, Inc., our largest investment, announced it is seeking to refinance its capital structure. Until the terms of the recapitalization have been finalized, we cannot fully assess the impact on our portfolio; however, at this time, we do not believe the impact will be material.
I agree with both of you that the current SLRC stock price is at an unusually attractive level. Relative to book value, SLRC hasn't been this low for six months and that was back when the Dow was more than 2200 points lower. As of yesterday's close the SLRC dividend was yielding 11.72%; was selling at just .93 times its' $22.02 book value; and had a potential total return of 34.86%.
st3ve27,
Thanks for your kind words. I'll try to put some words together on MCC in the next few days.
Jan
Recent SLRC News
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Form 40-17G - Fidelity Bond [Rule 17G-1(g)] • Edgar (US Regulatory) • 03/08/2024 05:30:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:53:22 PM
- SLR Investment Corp. Announces Quarter and Year Ended December 31, 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 09:01:00 PM
- SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System • GlobeNewswire Inc. • 02/01/2024 02:00:00 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2023 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:04:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:20:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:12:10 PM
- SLR Investment Corp. Announces Quarter Ended September 30, 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 09:03:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:03:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 08:01:27 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 09/29/2023 12:00:00 PM
- SLR Welcomes Chris York as a Partner • PR Newswire (US) • 09/18/2023 08:03:00 PM
- SLR Appoints Brad Coleman as an Operating Partner • PR Newswire (US) • 09/18/2023 08:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 03:00:12 PM
- SLR Investment Corp. Announces Monthly Distribution for September 2023 • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:31:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:15:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:30:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:07:38 PM
- SLR Investment Corp. Announces Quarter Ended June 30, 2023 Financial Results • GlobeNewswire Inc. • 08/08/2023 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 03:00:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM